Trulicity

EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk
BioSpace
Tue, 04/9/24 - 11:11 am
EMA
Europe
diabetes
weight loss
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Trulicity
Saxenda
Rybelsus
Victoza
Ozempic not tied to pancreatic cancer risk, study suggests
Beckers Hospital Review
Tue, 01/9/24 - 10:04 pm
Ozempic
Trulicity
type 2 diabetes
Novo Nordisk
GLP-1 agonist
pancreatic cancer
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Eli Lilly diabetes drugs Mounjaro and Trulicity in short supply, FDA says
Medical Marketing and Media
Mon, 12/19/22 - 10:17 pm
Eli Lilly
diabetes
drug shortages
Mounjaro
Trulicity
Novo Nordisk snags high-dose Ozempic approval, turning up the heat on Lilly's Trulicity
Fierce Pharma
Wed, 03/30/22 - 11:11 am
Novo Nordisk
Ozempic
diabetes
FDA
Eli Lilly
Trulicity
Trulicity Instagram post draws OPDP’s first untitled letter of 2022
RAPS.org
Mon, 01/24/22 - 11:37 pm
Eli Lilly
Trulicity
OPDP
FDA
social media
As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth
Fierce Pharma
Tue, 10/26/21 - 11:54 pm
Eli Lilly
earnings
Trulicity
Taltz
Verzenio
Emgality
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio
Fierce Pharma
Wed, 07/7/21 - 10:29 pm
Eli Lilly
pharma marketing
Olympics
Trulicity
Emgality
Verzenio
ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom
Fierce Pharma
Sun, 06/27/21 - 10:57 pm
Novo Nordisk
Ozempic
Eli Lilly
Rybelsus
Trulicity
diabetes
type 2 diabetes
Eli Lilly wraps up fifth and final tirzepatide PhIII trial, claiming a win over Sanofi's Lantus. The FDA awaits
Endpoints
Thu, 05/20/21 - 11:11 am
Eli Lilly
diabetes
Trulicity
tirzepatide
clinical trials
Pharma TV Ad Spending Trends: Companies in the Top Ten this Week
Xtalks
Thu, 05/13/21 - 11:46 pm
DTC ads
television ads
Dupixent
Trulicity
Rybelsus
Insider alleges Eli Lilly blocked her efforts to sound alarms about U.S. drug factory
Reuters
Sun, 03/14/21 - 11:03 pm
Eli Lilly
drug manufacturing
Trulicity
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
Fierce Pharma
Sun, 06/14/20 - 08:14 pm
ADA
diabetes
Eli Lilly
Trulicity
Novo Nordisk
Ozempic
Trulicity gets FDA nod for reducing CV risk in type 2 diabetes patients
Pharmaceutical Business Review
Mon, 02/24/20 - 10:42 am
Eli Lilly
Trulicity
FDA
type 2 diabetes
Cardiovascular
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
Fierce Biotech
Thu, 02/13/20 - 10:44 am
diabetes
insulin
Mt Sinai
Novo Nordisk
Ozempic
Rybelsus
Victoza
Eli Lilly
Trulicity
AstraZeneca
Bydureon
Lilly’s diabetes med Trulicity shrugs off Novo Nordisk challenge
Pharmaforum
Fri, 01/31/20 - 11:03 am
Eli Lilly
Trulicity
diabetes
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Fierce Pharma
Thu, 10/24/19 - 10:55 am
Eli Lilly
Trulicity
Taltz
immunology
type 2 diabetes
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Motley Fool
Fri, 09/27/19 - 09:10 am
diabetes
Eli Lilly
Merck
Novo Nordisk
GSK
Byetta
Victoza
Bydureon
Ozempic
Tanzeum
Trulicity
Rybelsus
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal
Investors Business Daily
Wed, 09/18/19 - 09:53 am
Novo Nordisk
Eli Lilly
oral semaglutide
Trulicity
diabetes

Pages